Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

SAN FRANCISCO, Aug. 2, 2023 /PRNewswire/ — Shasqi, Inc. (“Shasqi”) a clinical stage biotech company, whose mission is to revolutionize cancer treatment with click chemistry, today announced the formation of its Scientific Advisory Board (“SAB”) composed of leaders with decades of…

Click here to view original post